• News Highlights

  • Quintiles and Biogen Idec Announce Comprehensive Clinical Development Partnership

    RESEARCH TRIANGLE PARK, N.C. – April 24, 2014 – Quintiles, the world’s largest provider of biopharmaceutical development and commercial outsourcing services, and Biogen Idec (NASDAQ: BIIB) have entered into a five-year strategic clinical development agreement.

    Read Press Release
    View All Press Releases

  • Our Subscriptions

    Get updates on News, Events, Presentations and Broadcasts sent to via text or your personal email. You can also subscribe to our podcasts on iTunes to hear the latest broadcasts.


    Video Spotlights